Aurinia Pharmaceuticals, Inc. (AUPH)
16.58
-0.07
(-0.42%)
USD |
NASDAQ |
Aug 24, 16:00
16.58
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals 1 Year Total Returns (Daily) : 37.83% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 37.83% |
| August 20, 2026 | 43.80% |
| August 19, 2026 | 34.41% |
| August 18, 2026 | 25.20% |
| August 17, 2026 | 24.61% |
| August 14, 2026 | 27.96% |
| August 13, 2026 | 26.39% |
| August 12, 2026 | 36.48% |
| August 11, 2026 | 34.47% |
| August 10, 2026 | 35.88% |
| August 07, 2026 | 38.67% |
| August 06, 2026 | 38.93% |
| August 05, 2026 | 29.83% |
| August 04, 2026 | 30.39% |
| August 03, 2026 | 38.89% |
| July 31, 2026 | 60.95% |
| July 30, 2026 | 65.75% |
| July 29, 2026 | 69.70% |
| July 28, 2026 | 68.28% |
| July 27, 2026 | 70.44% |
| July 24, 2026 | 69.24% |
| July 23, 2026 | 65.83% |
| July 22, 2026 | 72.64% |
| July 21, 2026 | 81.44% |
| July 20, 2026 | 76.71% |
| Date | Value |
|---|---|
| July 17, 2026 | 75.96% |
| July 16, 2026 | 80.11% |
| July 15, 2026 | 79.09% |
| July 14, 2026 | 76.77% |
| July 13, 2026 | 82.16% |
| July 10, 2026 | 76.71% |
| July 09, 2026 | 97.74% |
| July 08, 2026 | 113.8% |
| July 07, 2026 | 117.1% |
| July 06, 2026 | 104.1% |
| July 02, 2026 | 108.4% |
| July 01, 2026 | 111.2% |
| June 30, 2026 | 100.4% |
| June 29, 2026 | 94.33% |
| June 26, 2026 | 99.65% |
| June 25, 2026 | 118.6% |
| June 24, 2026 | 131.3% |
| June 23, 2026 | 128.4% |
| June 22, 2026 | 125.6% |
| June 18, 2026 | 107.8% |
| June 17, 2026 | 104.0% |
| June 16, 2026 | 99.26% |
| June 15, 2026 | 95.60% |
| June 12, 2026 | 92.22% |
| June 11, 2026 | 95.92% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| enGene Therapeutics, Inc. | -54.48% |
| Medicus Pharma Ltd. | -88.91% |
| Sirona Biochem Corp. | -60.31% |
| Xenon Pharmaceuticals, Inc. | 59.17% |
| Psyence Biomedical Ltd. | -78.35% |